SAN FRANCISCO, March 12, 2026 /PRNewswire/ -- Stämm launched the High-Throughput Bioprocessor (HTB), an automated, single-use biomanufacturing platform for adherent and suspension cells. The HTB is ...

Good afternoon, everyone, and thank you for standing by, and welcome to the Corvus Pharmaceuticals Fourth Quarter and Full Year 2025 Business Update and Financial Results Conference Call. [Operator ...

Announced data from cohort 4 of soquelitinib atopic dermatitis Phase 1 trial demonstrating positive safety and efficacy results, including in ...

This study presents valuable findings that could potentially allow a deeper understanding of the immunopathogenesis underlying influenza infection in aged mice. The results are based on solid evidence ...

The challenges of connecting molecular changes to tissue structure and highlights the potential of multifractal frameworks to quantify complex biological patterns ...

Aspen Neuroscience, Inc., a clinical‑stage biotechnology company pioneering autologous regenerative therapies, today announced that the World Health Organization (WHO) has published Sasineprocel as ...

The survey conducted by AAHA and Gallant found 95% of industry professionals think stem cell therapy will become a new spectrum of care standard treatment option within 10 years. The American Animal ...

Nebius Group N.V. lands a $2B Nvidia deal to scale hyperscale AI cloud with Rubin/Vera/BlueField. Click for this NBIS stock update.

This important study advances our understanding of developmental timing mechanisms by studying the cleavage, nuclear translocation, and oscillation of the transcription factor MYRF-1 (vertebrate MYRF) ...

Cancers emerge from many different paths. One path begins early, in embryonic development, when a protein complex called PRC2 ...

People often compare the genome to a computer's program, with the cell using its genetic code to process environmental inputs and produce appropriate responses. Subscribe to our newsletter for the ...

A team of researchers at VCU Massey Comprehensive Cancer Center has identified a new pathway through which mutations in the tumor suppressor p53 gene—found very frequently in human tumors—hijack DNA ...